Exploring the implications of FDA’s renewed focus and commitment to expand the use of accelerated approval for gene therapy products.
Emily Marden, JD
Advertisement
Senior Counsel, Sidley Austin LLP
Articles by Emily Marden, JD
Advertisement
Latest Updated Articles
Accelerated Approval and the Promise of Gene TherapyPublished: September 27th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Honing the Power of AI for Next Generation Trial Oversight and Execution
3
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
4
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
